AN DIEGO — They may not explicitly mention President Trump. But the global recruiters who flock to the biotech sector’s big annual networking conference here this week will not be shy about trying to woo U.S. scientists and entrepreneurs frazzled by the Trump administration’s talk of slashing research funding, suspending immigration, and rejecting scientific consensus. In the age of “America First,” they don’t have to reach far to draw contrasts.

“We are open for talent. We are open for investments. We are open for business,” said Canada’s Reza Moridi, who serves as minister of research, innovation, and science in Ontario.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am PHD on protin &post graduate deploy in bio -informatics . I am working for 11 years as professor. I am searching for a better job with a attractive package.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy